大肠直肠癌的分子复杂性:途径,生物标志物和治疗策略
Zhengdong Yang1, Xinyang Wang1, Huiying Zhou1
1The First Department of Oncology, Heilongjiang University of Chinese Medicine, Heilongjiang, 150040, People's Republic of China.
Cancer management and research
|October 15, 2024
概括
结肠直肠癌 (CRC) 是一种由遗传和表观遗传变化驱动的复杂疾病. 了解其分子通路是改善诊断,预后和个性化治疗以获得更好的患者结果的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 结肠直肠癌 (CRC) 是全球主要的健康问题,也是癌症死亡的主要原因.
- CRC是由累积的遗传和表观遗传改变引起的,导致显著的瘤异质性.
- 这种异质性影响患者的预后和对治疗的反应,需要更深入的分子理解.
研究的目的:
- 为了审查结直肠癌的分子复杂性.
- 阐明参与CRC启动,进展,入侵和转移的中央信号通路.
- 突出分子洞察力对于改善CRC诊断,预后和治疗策略的重要性.
主要方法:
- 本综述综合了关于CRC分子景观的当前研究.
- 它详细介绍了三种主要的致癌途径:染色体不稳定性 (CIN),微卫星不稳定性 (MSI) 和CpG岛甲基器表型 (CIMP).
- 该审查审查了信号网络,表观遗传修饰和基因突变,这些突变推动了CRC的发展和进展.
主要成果:
- CRC分子复杂性的特点是不同的途径 (CIN,MSI,CIMP) 和遗传/表观遗传变化.
- 这些途径影响CRC的启动,进展,转移和治疗反应.
- 了解这些分子变异对于为个体患者量身定制治疗至关重要.
结论:
- CRC的多样化分子框架对通用治疗疗效提出了挑战.
- 基于分子分析的个性化治疗方法对于改善患者的治疗结果至关重要.
- 对CRC途径和生物标志物的持续研究将推动开发更精确,更有效的癌症疗法.
相关概念视频
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K